ALGS vs MSCI · rev $3.6M vs P/E 37, rev $2.86B
Aligos Therapeutics Inc (ALGS) versus MSCI Inc (MSCI) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
MSCI Inc (MSCI) is a financial data & stock exchanges company listed on US.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported MSCI revenue for 2024-12-31 was $2.86B. Net income was $1.11B. Revenue was up 12.9% from 2023-12-31 to 2024-12-31. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
ALGS currently screens at market cap $44.1M. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
Not investment advice. Open the ALGS and MSCI stock pages for the full models.
Not investment advice.